Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer

(MedPage Today) -- Combining chemotherapy with one or two immune checkpoint inhibitors (ICIs) as second-line treatment for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma failed to improve progression-free survival (PFS) at 4...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news